97 related articles for article (PubMed ID: 8865534)
1. Tissue factor pathway inhibitor production by human mesangial cells in culture.
Yamabe H; Osawa H; Inuma H; Kaizuka M; Tamura N; Tsunoda S; Fujita Y; Shirato K; Onodera K
Thromb Haemost; 1996 Aug; 76(2):215-9. PubMed ID: 8865534
[TBL] [Abstract][Full Text] [Related]
2. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor production by human proximal tubular epithelial cells in culture.
Sugawara T; Yamabe H; Osawa H; Kaizuka M; Shirato K; Nakamura M; Tamura M; Okumura K
Thromb Res; 2003 May; 110(2-3):141-7. PubMed ID: 12893029
[TBL] [Abstract][Full Text] [Related]
4. Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits.
Erlich JH; Apostolopoulos J; Wun TC; Kretzmer KK; Holdsworth SR; Tipping PG
J Clin Invest; 1996 Jul; 98(2):325-35. PubMed ID: 8755641
[TBL] [Abstract][Full Text] [Related]
5. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and expression of tissue factor pathway inhibitor by serum-stimulated fibroblasts, vascular smooth muscle cells and cardiac myocytes.
Bajaj MS; Steer S; Kuppuswamy MN; Kisiel W; Bajaj SP
Thromb Haemost; 1999 Dec; 82(6):1663-72. PubMed ID: 10613653
[TBL] [Abstract][Full Text] [Related]
7. Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells.
Giraux JL; Tapon-Bretaudière J; Matou S; Fischer AM
Thromb Haemost; 1998 Oct; 80(4):692-5. PubMed ID: 9798992
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells.
Horie S; Hiraishi S; Hirata Y; Kazama M; Matsuda J
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):277-85. PubMed ID: 11085919
[TBL] [Abstract][Full Text] [Related]
9. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administration.
Cella G; Cipriani A; Tommasini A; Rampin E; Sbarai A; Rocconi R; Mazzaro G; Luzzatto G
Semin Thromb Hemost; 1997; 23(1):45-9. PubMed ID: 9156410
[TBL] [Abstract][Full Text] [Related]
11. Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies.
Nagase H; Enjyoji K; Kamikubo Y; Kitazato KT; Kitazato K; Saito H; Kato H
Thromb Haemost; 1997 Aug; 78(2):864-70. PubMed ID: 9268186
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
[TBL] [Abstract][Full Text] [Related]
13. Mesangial cell Fas ligand: upregulation in human lupus nephritis and NF-kappaB-mediated expression in cultured human mesangial cells.
Tsukinoki T; Sugiyama H; Sunami R; Kobayashi M; Onoda T; Maeshima Y; Yamasaki Y; Makino H
Clin Exp Nephrol; 2004 Sep; 8(3):196-205. PubMed ID: 15480896
[TBL] [Abstract][Full Text] [Related]
14. Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.
Martinez-Sales V; Vila V; Réganon E; Oms JG; Aznar J
Haematologica; 2003 Jun; 88(6):694-9. PubMed ID: 12801846
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications.
Bajaj MS; Ghosh M; Bajaj SP
J Thromb Haemost; 2007 Jul; 5(7):1493-9. PubMed ID: 17470199
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor.
Mukherjee M; Kakkar VV
Thromb Haemost; 1999 Dec; 82(6):1648-51. PubMed ID: 10613650
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidylcholine decreases the synthesis of tissue factor pathway inhibitor in human umbilical vein endothelial cells.
Sato N; Kokame K; Miyata T; Kato H
Thromb Haemost; 1998 Jan; 79(1):217-21. PubMed ID: 9459350
[TBL] [Abstract][Full Text] [Related]
18. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J
Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
[TBL] [Abstract][Full Text] [Related]
20. Heparin-binding epidermal growth factor-like growth factor, an immediate-early gene for mesangial cells, is up-regulated in the Thy-1.1 model.
Polihronis M; Murphy BF; Pearse MJ; Power DA
Exp Nephrol; 1996; 4(5):271-8. PubMed ID: 8931982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
